Pages that link to "Q54631175"
Jump to navigation
Jump to search
The following pages link to Piperacillin/tazobactam in complicated urinary tract infections. (Q54631175):
Displaying 11 items.
- Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections (Q33649676) (← links)
- Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis (Q33701687) (← links)
- Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections (Q34458678) (← links)
- Cross-Canada survey of resistance of 2747 aerobic blood culture isolates to piperacillin/tazobactam and other antibiotics (Q35650111) (← links)
- Study of the comparative activity of piperacillin/tazobactam with currently available antibiotics against 8206 aerobic isolates (Q35891315) (← links)
- Complicated urinary tract infection in adults (Q36170941) (← links)
- Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis (Q37052814) (← links)
- Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential (Q40389389) (← links)
- Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections (Q43890461) (← links)
- Comparative in vitro activity of piperacillin, piperacillin–sulbactam and piperacillin-tazobactam against nosocomial pathogens isolated from intensive care patients (Q44655203) (← links)
- Evolution of antimicrobial prophylaxis in cardiovascular surgery (Q73055159) (← links)